Optimizing pH-responsive polymeric micelles for drug delivery in a cancer photodynamic therapy model

被引:73
作者
Le Garrec, D
Taillefer, J
Van Lier, JE
Lenaerts, V
Leroux, JC
机构
[1] Univ Montreal, Fac Pharm, Canada Res Chair Drug Delivery, Montreal, PQ H3C 3J7, Canada
[2] Univ Sherbrooke, Fac Med, Dept Med Nucl & Radiobiol, MRC Grp Radiat Sci, Sherbrooke, PQ J1H 5N4, Canada
[3] Labopharm Inc, Laval, PQ H7V 3Z3, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
polymeric micelles; pH-sensitivity; phthalocyanine; poly(N-isopropylacrylamide); N-vinyl-2-pyrrolidone;
D O I
10.1080/1061186021000001887
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Different pH-sensitive, randomly- and terminally-alkylated N-isopropylacrylamide (NIPAM) copolymers were synthesized and used to prepare pH-responsive polymeric micelles (PM). These copolymers were modified from previously-studied copolymers by incorporating an additional hydrophilic monomer, N-vinyl-2-pyrrolidone (VP) to decrease uptake by the mononuclear phagocyte system (MPS) and improve localization in tumors. VP lowered the phase transition pH of the copolymers but did not affect the onset of micellization. The in vitro cytotoxicity of the copolymers was evaluated on EMT-6 mouse mammary tumor cells in comparison to Cremophor EL (CRM). The anticancer photosensitizer aluminum chloride phthalocyanine (AlClPc) was loaded into the PM with a standard dialysis procedure. Biodistribution and in vivo photodynamic activity were then evaluated in Balb/c mice bearing intradermal EMT-6 tumors. All NIPAM copolymers demonstrated substantially lower cell cytotoxicity than the control surfactant CRM. In vivo, similar AlClPc tumor uptake was observed for the PM and CRM formulations. However, the PM appeared to exhibit greater activity in vivo than CRM formulation at an AlClPc subtherapeutic dose. Therefore, NIPAM-based copolymers containing VP units represent promising alternatives for the formulation of poorly water-soluble phthalocyanines.
引用
收藏
页码:429 / 437
页数:9
相关论文
共 47 条
[1]   Nano-engineering block copolymer aggregates for drug delivery [J].
Allen, C ;
Maysinger, D ;
Eisenberg, A .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :3-27
[2]  
*BASF, 1997, CREM EL BASF AKT LUD, P1
[3]  
BENHAMED A, 2001, PHARM RES, V18, P323
[4]   A long-circulating co-polymer in ''passive targeting'' to solid tumors [J].
Bogdanov, A ;
Wright, SC ;
Marecos, EM ;
Bogdanova, A ;
Martin, C ;
Petherick, P ;
Weissleder, R .
JOURNAL OF DRUG TARGETING, 1997, 4 (05) :321-&
[5]   Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice [J].
Brasseur, N ;
Ouellet, R ;
La Madeleine, C ;
van Lier, JE .
BRITISH JOURNAL OF CANCER, 1999, 80 (10) :1533-1541
[6]   Efficacy and mechanism of aluminium phthalocyanine and its sulphonated derivatives mediated photodynamic therapy on murine tumours [J].
Chan, WS ;
Brasseur, N ;
LaMadeleine, C ;
Ouellet, R ;
vanLier, JE .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (11) :1855-1859
[7]  
CHUANG LF, 1991, ANTICANCER RES, V11, P1517
[8]   Vinylpyrrolidone-N,N′-dimethylacrylamide water-soluble copolymers:: synthesis, physical-chemical properties and proteic interactions [J].
de Queiroz, AAA ;
Gallardo, A ;
San Román, J .
BIOMATERIALS, 2000, 21 (16) :1631-1643
[9]   SUSPECTED ANAPHYLACTIC REACTION TO CREMOPHOR EL [J].
DYE, D ;
WATKINS, J .
BRITISH MEDICAL JOURNAL, 1980, 280 (6228) :1353-1353
[10]   Graft copolymers for biomedical applications prepared by free radical polymerization of poly(L-lactide) macromonomers with vinyl and acrylic monomers [J].
Eguiburu, JL ;
FernandezBerridi, MJ ;
Roman, JS .
POLYMER, 1996, 37 (16) :3615-3622